POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.
High Impact

Congressional Hearing on Reauthorizing the Office of National Drug Control Policy

Original title: OFFICE OF NATIONAL DRUG CONTROL POLICY: REAUTHORIZATION IN THE 115TH CONGRESS

Record date · January 1, 2018

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This document is a transcript from a 2017 House Committee on Oversight and Government Reform hearing regarding the of the Office of National Drug Control Policy (). The hearing focused on the federal government's role in addressing the national opioid and drug abuse crisis.

Why it matters

The hearing examines the federal agency responsible for coordinating national drug control efforts, which impacts how billions in federal funding and strategy are allocated to combat the opioid epidemic and drug-related deaths.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Office of National Drug Control Policy

The agency is subject to congressional reauthorization, which determines its legal mandate and operational scope.

Directly affected

Public health officials and addiction advocates

These groups are impacted by the federal drug policies and funding strategies coordinated by the ONDCP.

Key Facts

  • The hearing was held on July 26, 2017, by the House Committee on Oversight and Government Reform.
  • The primary purpose of the hearing was to discuss the reauthorization of the Office of National Drug Control Policy (ONDCP).
  • The ONDCP was originally established by the Anti-Drug Abuse Act of 1988.
  • Opioids, including heroin and prescription pain relievers, were identified as the leading cause of drug-related overdose deaths in the U.S.
Show all 7 facts
  • The national death rate from opioid overdoses has more than doubled since 2000.
  • In 2015, South Carolina reported 95 deaths from heroin and over 560 deaths from prescription opioid abuse.
  • The hearing included testimony from the ONDCP, the Government Accountability Office (GAO), academic experts, and policy advocates.

Frequently Asked Questions

What is the Office of National Drug Control Policy (ONDCP)?
The is a federal agency established in 1988 to coordinate drug control programs and policies across the U.S. government.
Why was this hearing held?
The hearing was held to review the agency's performance and strategy as part of the formal process in the 115th Congress.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Opioid Crisis

The hearing highlights a shift in congressional oversight focus toward the opioid epidemic as a primary public health and safety crisis.

Connected Entities

Don Flattery, Committee on Oversight and Government Reform, Keith Humphreys and 4 more
PersonDon Flattery“Addiction Policy Advocate”Map →
OrganizationCommittee on Oversight and Government Reform“House committee conducting the hearing”Map →
PersonKeith Humphreys“Professor of Psychiatry and Behavioral Sciences at Stanford University”Map →
PersonDiana Maurer“Director of Justice and Law Enforcement Issues at the GAO”Map →
OrganizationOffice of National Drug Control Policy“Federal agency under review for reauthorization”Map →
PersonTrey Gowdy“Chairman of the Committee on Oversight and Government Reform”Map →
PersonRichard Baum“Acting Director of the Office of National Drug Control Policy”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record